Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Genet Med ; 20(12): 1515-1521, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-29565420

RESUMO

PURPOSE: There is increasing demand from the public for direct-to-consumer (DTC) genetic tests, and the US Food and Drug Administration limits the type of health-related claims DTC tests can market. Some DTC companies provide raw genotyping data to customers if requested, and these raw data may include variants occurring in genes recommended by the American College of Medical Genetics and Genomics to be reported as incidental/secondary findings. The purpose of this study was to review the outcome of requests for clinical confirmation of DTC results that were received by our laboratory and to analyze variant classification concordance. METHODS: We identified 49 patient samples received for further testing that had previously identified genetic variants reported in DTC raw data. For each case identified, information pertaining to the outcome of clinical confirmation testing as well as classification of the DTC variant was collected and analyzed. RESULTS: Our analyses indicated that 40% of variants in a variety of genes reported in DTC raw data were false positives. In addition, some variants designated with the "increased risk" classification in DTC raw data or by a third-party interpretation service were classified as benign at Ambry Genetics as well as several other clinical laboratories, and are noted to be common variants in publicly available population frequency databases. CONCLUSION: Our results demonstrate the importance of confirming DTC raw data variants in a clinical laboratory that is well versed in both complex variant detection and classification.


Assuntos
Testes Genéticos , Variação Genética , Genômica , Adulto , Idoso , Triagem e Testes Direto ao Consumidor , Feminino , Humanos , Internet , Masculino , Pessoa de Meia-Idade , Estados Unidos , United States Food and Drug Administration
3.
J Genet Couns ; 23(4): 539-51, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24449059

RESUMO

Whole exome sequencing (WES) uses next generation sequencing technology to provide information on nearly all functional, protein-coding regions in an individual's genome. Due to the vast amount of information and incidental findings that can be generated from this technology, patient preferences must be investigated to help clinicians consent and return results to patients. Patients (n = 19) who were previously clinically diagnosed with Lynch syndrome, but received uninformative negative Lynch syndrome genetic results through traditional molecular testing methods participated in semi-structured interviews after WES testing but before return of results to explore their views of WES and preferences for return of results. Analyses of interview results found that nearly all participants believed that the benefits of receiving all possible results generated from WES outweighed the undesirable effects. The majority of participants conveyed that relative to coping with a cancer diagnosis, information generated from WES would be manageable. Importantly, participants' experience with Lynch syndrome influenced their notions of genetic determinism, tolerance for uncertain results, and family communication plans. Participants would prefer to receive WES results in person from a genetic counselor or medical geneticist so that an expert could help explain the meaning and implications of the potentially large quantity and range of complicated results. These results underscore the need to study various populations with regard to the clinical use of WES in order to effectively and empathetically communicate the possible implications of this new technology and return results.


Assuntos
Neoplasias Colorretais Hereditárias sem Polipose/genética , Exoma , Testes Genéticos , Preferência do Paciente , Análise de Sequência , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Aconselhamento Genético , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem
4.
Am J Hum Biol ; 23(4): 567-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21630365

RESUMO

OBJECTIVES: This study seeks to identify associations among genomic biogeographic ancestry (BGA), quantitative iris color, and iris texture traits contributing to population-level variation in these phenotypes. METHODS: DNA and iris photographs were collected from 300 individuals across three variably admixed populations (Portugal, Brazil, and Cape Verde). Two raters scored the photos for pigmentation spots, Fuchs' crypts, contraction furrows, and Wolflinn nodes. Iris color was quantified from RGB values. Maximum likelihood estimates of individual BGA were calculated from 176 ancestry informative markers. RESULTS: Pigmentation spots, Fuchs' crypts, contraction furrows, and iris color show significant positive correlation with increasing European BGA. Only contraction furrows are correlated with iris color. CONCLUSIONS: The relationship between BGA and iris texture illustrates a genetic contribution to this population-level variation.


Assuntos
Genômica/estatística & dados numéricos , Iris/anatomia & histologia , Fenótipo , Brasil , Cabo Verde , DNA/análise , Humanos , Iris/fisiologia , Funções Verossimilhança , Fotografação , Filogeografia , Portugal , Análise de Regressão , Estatística como Assunto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA